Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: Effects of cytochrome P450-P450 and cytochrome P450-b(5) interactions

被引:120
|
作者
Yamazaki, H
Gillam, EMJ
Dong, MS
Johnson, WW
Guengerich, FP
Shimada, T
机构
[1] OSAKA PREFECTURAL INST PUBL HLTH,HIGASHINARI KU,OSAKA 537,JAPAN
[2] UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,ST LUCIA,QLD 4072,AUSTRALIA
[3] VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[4] VANDERBILT UNIV,SCH MED,CTR MOL TOXICOL,NASHVILLE,TN 37232
关键词
human P450; b(5); CYP2C10; CYP2C9; CYP3A4; CYP2E1; CYP2D6; CYP1A2; CYP1A1; reconstitution; xenobiotics; drug oxidation;
D O I
10.1006/abbi.1997.0125
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tolbutamide methyl hydroxylation and S-warfarin 7-hydroxylation activities were reconstituted in systems containing recombinant human cytochrome P450 (P450 or CYP) 2C10(2C9) and the optimal conditions for the systems were compared with those of bufuralol 1'-hydroxylation by CYP1A1, theophylline 8-hydroxylation by CYP1A2, bufuralol 1'-hydroxylation by CYP2D6, chlorzoxazone 6-hydroxylation by CYP2E1, and testosterone 6 beta-hydroxylation by CYP3A4. CYP2C10 required cytochrome b(5) (b(5)) for optimal rates of tolbutamide and S-warfarin oxidations and b(5) could be replaced by apo-b(5); apo-b(5) and b(5) effects on the reconstituted systems have already been reported in systems containing CYP3A4 for the oxidation of testosterone and nifedipine and for the rapid reduction of CYP3A4 by NADPH-P450 reductase (H. Yamazaki et al., 1996, J. Biol. Chem. 271, 27438-27444). Stopped-flow studies, however, suggested that apo-b(5) as well as b(5) did not cause stimulation of the reduction of CYP2C10 by NADPH-P450 reductase, while the reduction rates were dependent on the substrates in reconstituted systems. Chlorzoxazone 6-hydroxylation by CYP2E1 was stimulated by b(5), but not by apo-b(5), in reconstituted systems. Neither apo- nor hole-b(5) increased bufuralol 1'-hydroxylation activity by CYP1A1 or 2D6 or theophylline 8-hydroxylation by CYP1A2. Interestingly, we found that testosterone 6 beta-hydroxylation by CYP3A4 was stimulated by CYP1A2 (and also by a modified form in which the first 36 residues of the native human protein were removed) and CYP1A1 as well as by b(5), and such stimulations were not seen when other P450 proteins (e.g., CYP2C10, 2D6, or 2E1) were added to the reconstituted systems. In contrast, substrate oxidations by CYP2C10 and CYP2E1 were not stimulated by other P450 proteins. The present results suggest that there are differences in optimal conditions for reconstitution of substrate oxidations by various forms of human P450 enzymes, and in some P45O-catalyzed reactions protein-protein interactions between P450 and b(5) and other P450 proteins are very important in some oxidations catalyzed by CYP2C10, 2E1, and 3A4. (C) 1997 Academic Press.
引用
收藏
页码:329 / 337
页数:9
相关论文
共 50 条
  • [41] Cytochrome P450 and atherosclerosis
    Luoma, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (04) : 484 - 484
  • [42] Cytochrome p450 enzymes
    Donaldson, D
    JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2000, 120 (03): : 150 - 151
  • [43] Blueing with cytochrome P450
    Brennan, M
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (02) : 30 - 30
  • [44] QSAR of cytochrome P450
    Hansch, C
    Mekapati, SB
    Kurup, A
    Verma, RP
    DRUG METABOLISM REVIEWS, 2004, 36 (01) : 105 - 156
  • [45] Introduction: Cytochrome P450
    Masters, BSS
    FASEB JOURNAL, 1996, 10 (02): : 205 - 205
  • [46] Cytochrome P450 and Steatosis
    Jose Gomez-Lechon, Maria
    Jover, Ramiro
    Teresa Donato, Maria
    CURRENT DRUG METABOLISM, 2009, 10 (07) : 692 - 699
  • [47] Cytochrome P450 - Preface
    Lu, AYH
    CURRENT DRUG METABOLISM, 2001, 2 (02) : U4 - U4
  • [48] Cytochrome P450 engineering
    Pompon, Denis
    Truan, Gilles
    Urban, Philippe
    BIOFUTUR, 2008, (288) : 34 - 38
  • [49] Preface: Cytochrome P450
    Plettner, Erika
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2018, 1866 (01): : 1 - 1
  • [50] Interactions between cytochrome P450 and cytochrome b5
    Schenkman, JB
    Jansson, I
    DRUG METABOLISM REVIEWS, 1999, 31 (02) : 351 - 364